HEADER TOXIN/PROTEIN BINDING 09-NOV-06 2NUD TITLE THE STRUCTURE OF THE TYPE III EFFECTOR AVRB COMPLEXED WITH TITLE 2 A HIGH-AFFINITY RIN4 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: AVIRULENCE B PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: RPM1-INTERACTING PROTEIN 4; COMPND 7 CHAIN: C, D; COMPND 8 FRAGMENT: RIN4 PEPTIDE, RESIDUES 142-176; COMPND 9 SYNONYM: RIN4; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS SYRINGAE PV. GLYCINEA; SOURCE 3 ORGANISM_TAXID: 318; SOURCE 4 STRAIN: PV GLYCINEA; SOURCE 5 GENE: AVRB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEX-HTA; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: RIN4 PEPTIDE SYNTHESIZED NATURALLY FROM THE SOURCE 14 ARABIDOPSIS RIN4 SEQUENCE. N- AND C-TERMINI BLOCKED BY SOURCE 15 METHYLATION AND AMIDATION, RESPECTIVELY KEYWDS AVRB RIN4 HIGH-AFFINITY CRYSTAL STRUCTURE, TOXIN/PROTEIN KEYWDS 2 BINDING COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.U.SINGER,D.DESVEAUX,A.J.WU,B.MCNULTY,J.SONDEK,J.L.DANGL REVDAT 2 24-FEB-09 2NUD 1 VERSN REVDAT 1 22-MAY-07 2NUD 0 JRNL AUTH D.DESVEAUX,A.U.SINGER,A.J.WU,B.C.MCNULTY, JRNL AUTH 2 L.MUSSELWHITE,Z.NIMCHUK,J.SONDEK,J.L.DANGL JRNL TITL TYPE III EFFECTOR ACTIVATION VIA NUCLEOTIDE JRNL TITL 2 BINDING, PHOSPHORYLATION, AND HOST TARGET JRNL TITL 3 INTERACTION. JRNL REF PLOS PATHOG. V. 3 E48 2007 JRNL REFN ISSN 1553-7366 JRNL PMID 17397263 JRNL DOI 10.1371/JOURNAL.PPAT.0030048 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.500 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1203820.950 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 26385 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1273 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3867 REMARK 3 BIN R VALUE (WORKING SET) : 0.2410 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 185 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5012 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 321 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.31000 REMARK 3 B22 (A**2) : 0.24000 REMARK 3 B33 (A**2) : -2.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.42000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.20 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.20 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.75 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.960 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.050 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.100 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.290 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 42.79 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : TMN_XPLOR_PAR.TXT REMARK 3 PARAMETER FILE 5 : ETF_XPLOR_PAR.TXT REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : TMN_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 5 : ETF_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NUD COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-NOV-06. REMARK 100 THE RCSB ID CODE IS RCSB040312. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : OSMIC CONFOCAL "BLUE" REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29016 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 99.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.43700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1NH1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1:2-3 RATIO OF PROTEIN TO PEPTIDE REMARK 280 WITH AVRB AT ~12 MG/ML MIXED WITH AN EQUAL VOLUME OF WELL REMARK 280 SOLUTION (100 MM TRIS, PH 7.5, 20-30% PEG 550 MME), VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.08300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAIN B AND D (AVRB AND PEPTIDE COMPLEX NO 2) ARE REMARK 300 GENERATED FROM CHAINS A AND C (COMPLEX NO 1) BY APPLYING THE REMARK 300 TRANSFORMATION TO COMPLEX 1 OF: [-1 0.0004 0.0008 + [-0.0584 - REMARK 300 0.0004 -1 0.0023 -10.7947 0.0008 0.0023 1 ] -59.8951] (IN THE REMARK 300 FORM OF [X11 X12 X13 + [Y1 X21 X22 X23 Y2 X31 X32 X33] Y3] ) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE AUTHORS STATE THAT FOR THE PEPTIDE (CHAINS C AND D), REMARK 400 THE N- AND C-TERMINI ARE BLOCKED (ACETYLATED AT THE REMARK 400 N-TERMINUS AND AMIDATED AT THE C-TERMINUS). REMARK 400 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 CYS A 3 REMARK 465 VAL A 4 REMARK 465 SER A 5 REMARK 465 SER A 6 REMARK 465 LYS A 7 REMARK 465 SER A 8 REMARK 465 THR A 9 REMARK 465 THR A 10 REMARK 465 VAL A 11 REMARK 465 LEU A 12 REMARK 465 SER A 13 REMARK 465 PRO A 14 REMARK 465 GLN A 15 REMARK 465 THR A 16 REMARK 465 SER A 17 REMARK 465 PHE A 18 REMARK 465 ASN A 19 REMARK 465 GLU A 20 REMARK 465 ALA A 21 REMARK 465 SER A 22 REMARK 465 ARG A 23 REMARK 465 THR A 24 REMARK 465 SER A 25 REMARK 465 SER A 54 REMARK 465 SER A 55 REMARK 465 GLN A 104 REMARK 465 ARG A 105 REMARK 465 GLY A 106 REMARK 465 GLY B -1 REMARK 465 ALA B 0 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 CYS B 3 REMARK 465 VAL B 4 REMARK 465 SER B 5 REMARK 465 SER B 6 REMARK 465 LYS B 7 REMARK 465 SER B 8 REMARK 465 THR B 9 REMARK 465 THR B 10 REMARK 465 VAL B 11 REMARK 465 LEU B 12 REMARK 465 SER B 13 REMARK 465 PRO B 14 REMARK 465 GLN B 15 REMARK 465 THR B 16 REMARK 465 SER B 17 REMARK 465 PHE B 18 REMARK 465 ASN B 19 REMARK 465 GLU B 20 REMARK 465 ALA B 21 REMARK 465 SER B 22 REMARK 465 ARG B 23 REMARK 465 THR B 24 REMARK 465 SER B 25 REMARK 465 SER B 54 REMARK 465 SER B 55 REMARK 465 GLN B 104 REMARK 465 ARG B 105 REMARK 465 GLY B 106 REMARK 465 PRO C 142 REMARK 465 GLU C 143 REMARK 465 LYS C 144 REMARK 465 VAL C 145 REMARK 465 THR C 146 REMARK 465 VAL C 147 REMARK 465 VAL C 148 REMARK 465 PRO C 149 REMARK 465 ARG C 173 REMARK 465 GLU C 174 REMARK 465 GLU C 175 REMARK 465 ARG C 176 REMARK 465 PRO D 142 REMARK 465 GLU D 143 REMARK 465 LYS D 144 REMARK 465 VAL D 145 REMARK 465 THR D 146 REMARK 465 VAL D 147 REMARK 465 VAL D 148 REMARK 465 PRO D 149 REMARK 465 ARG D 173 REMARK 465 GLU D 174 REMARK 465 GLU D 175 REMARK 465 ARG D 176 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 107 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 48 79.98 -114.08 REMARK 500 PRO A 130 31.41 -95.15 REMARK 500 ASN A 152 8.79 -68.46 REMARK 500 LEU A 175 -109.88 -109.83 REMARK 500 ASN B 152 8.52 -69.66 REMARK 500 LEU B 175 -110.12 -108.94 REMARK 500 PRO B 212 -33.84 -39.94 REMARK 500 MET B 262 72.82 49.10 REMARK 500 CYS B 320 -65.21 -100.05 REMARK 500 ASP C 155 59.01 -100.83 REMARK 500 SER C 161 151.51 -43.81 REMARK 500 ASP D 155 47.40 -101.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C1081 DISTANCE = 5.14 ANGSTROMS REMARK 525 HOH A1154 DISTANCE = 6.00 ANGSTROMS REMARK 525 HOH B1182 DISTANCE = 5.10 ANGSTROMS REMARK 525 HOH B1266 DISTANCE = 7.84 ANGSTROMS REMARK 525 HOH A1293 DISTANCE = 6.38 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A 1501 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS B 1502 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS B 1503 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A 1504 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETF A 2001 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETF B 2002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NH1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TYPE III EFFECTOR AVRB FROM REMARK 900 PSEUDOMONAS SYRINGAE REMARK 900 RELATED ID: 2NUN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TYPE III EFFECTOR AVRB COMPLEXED REMARK 900 WITH ADP DBREF 2NUD A 1 321 UNP P13835 AVRB_PSESG 1 321 DBREF 2NUD B 1 321 UNP P13835 AVRB_PSESG 1 321 DBREF 2NUD C 142 176 UNP Q8GYN5 RIN4_ARATH 142 176 DBREF 2NUD D 142 176 UNP Q8GYN5 RIN4_ARATH 142 176 SEQADV 2NUD GLY A -1 UNP P13835 CLONING ARTIFACT SEQADV 2NUD ALA A 0 UNP P13835 CLONING ARTIFACT SEQADV 2NUD GLY B -1 UNP P13835 CLONING ARTIFACT SEQADV 2NUD ALA B 0 UNP P13835 CLONING ARTIFACT SEQRES 1 A 323 GLY ALA MET GLY CYS VAL SER SER LYS SER THR THR VAL SEQRES 2 A 323 LEU SER PRO GLN THR SER PHE ASN GLU ALA SER ARG THR SEQRES 3 A 323 SER PHE ARG ALA LEU PRO GLY PRO SER GLN ARG GLN LEU SEQRES 4 A 323 GLU VAL TYR ASP GLN CYS LEU ILE GLY ALA ALA ARG TRP SEQRES 5 A 323 PRO ASP ASP SER SER LYS SER ASN THR PRO GLU ASN ARG SEQRES 6 A 323 ALA TYR CYS GLN SER MET TYR ASN SER ILE ARG SER ALA SEQRES 7 A 323 GLY ASP GLU ILE SER ARG GLY GLY ILE THR SER PHE GLU SEQRES 8 A 323 GLU LEU TRP GLY ARG ALA THR GLU TRP ARG LEU SER LYS SEQRES 9 A 323 LEU GLN ARG GLY GLU PRO LEU TYR SER ALA PHE ALA SER SEQRES 10 A 323 GLU ARG THR SER ASP THR ASP ALA VAL THR PRO LEU VAL SEQRES 11 A 323 LYS PRO TYR LYS SER VAL LEU ALA ARG VAL VAL ASP HIS SEQRES 12 A 323 GLU ASP ALA HIS ASP GLU ILE MET GLN ASP ASN LEU PHE SEQRES 13 A 323 GLY ASP LEU ASN VAL LYS VAL TYR ARG GLN THR ALA TYR SEQRES 14 A 323 LEU HIS GLY ASN VAL ILE PRO LEU ASN THR PHE ARG VAL SEQRES 15 A 323 ALA THR ASP THR GLU TYR LEU ARG ASP ARG VAL ALA HIS SEQRES 16 A 323 LEU ARG THR GLU LEU GLY ALA LYS ALA LEU LYS GLN HIS SEQRES 17 A 323 LEU GLN ARG TYR ASN PRO ASP ARG ILE ASP HIS THR ASN SEQRES 18 A 323 ALA SER TYR LEU PRO ILE ILE LYS ASP HIS LEU ASN ASP SEQRES 19 A 323 LEU TYR ARG GLN ALA ILE SER SER ASP LEU SER GLN ALA SEQRES 20 A 323 GLU LEU ILE SER LEU ILE ALA ARG THR HIS TRP TRP ALA SEQRES 21 A 323 ALA SER ALA MET PRO ASP GLN ARG GLY SER ALA ALA LYS SEQRES 22 A 323 ALA GLU PHE ALA ALA ARG ALA ILE ALA SER ALA HIS GLY SEQRES 23 A 323 ILE GLU LEU PRO PRO PHE ARG ASN GLY ASN VAL SER ASP SEQRES 24 A 323 ILE GLU ALA MET LEU SER GLY GLU GLU GLU PHE VAL GLU SEQRES 25 A 323 LYS TYR ARG SER LEU LEU ASP SER ASP CYS PHE SEQRES 1 B 323 GLY ALA MET GLY CYS VAL SER SER LYS SER THR THR VAL SEQRES 2 B 323 LEU SER PRO GLN THR SER PHE ASN GLU ALA SER ARG THR SEQRES 3 B 323 SER PHE ARG ALA LEU PRO GLY PRO SER GLN ARG GLN LEU SEQRES 4 B 323 GLU VAL TYR ASP GLN CYS LEU ILE GLY ALA ALA ARG TRP SEQRES 5 B 323 PRO ASP ASP SER SER LYS SER ASN THR PRO GLU ASN ARG SEQRES 6 B 323 ALA TYR CYS GLN SER MET TYR ASN SER ILE ARG SER ALA SEQRES 7 B 323 GLY ASP GLU ILE SER ARG GLY GLY ILE THR SER PHE GLU SEQRES 8 B 323 GLU LEU TRP GLY ARG ALA THR GLU TRP ARG LEU SER LYS SEQRES 9 B 323 LEU GLN ARG GLY GLU PRO LEU TYR SER ALA PHE ALA SER SEQRES 10 B 323 GLU ARG THR SER ASP THR ASP ALA VAL THR PRO LEU VAL SEQRES 11 B 323 LYS PRO TYR LYS SER VAL LEU ALA ARG VAL VAL ASP HIS SEQRES 12 B 323 GLU ASP ALA HIS ASP GLU ILE MET GLN ASP ASN LEU PHE SEQRES 13 B 323 GLY ASP LEU ASN VAL LYS VAL TYR ARG GLN THR ALA TYR SEQRES 14 B 323 LEU HIS GLY ASN VAL ILE PRO LEU ASN THR PHE ARG VAL SEQRES 15 B 323 ALA THR ASP THR GLU TYR LEU ARG ASP ARG VAL ALA HIS SEQRES 16 B 323 LEU ARG THR GLU LEU GLY ALA LYS ALA LEU LYS GLN HIS SEQRES 17 B 323 LEU GLN ARG TYR ASN PRO ASP ARG ILE ASP HIS THR ASN SEQRES 18 B 323 ALA SER TYR LEU PRO ILE ILE LYS ASP HIS LEU ASN ASP SEQRES 19 B 323 LEU TYR ARG GLN ALA ILE SER SER ASP LEU SER GLN ALA SEQRES 20 B 323 GLU LEU ILE SER LEU ILE ALA ARG THR HIS TRP TRP ALA SEQRES 21 B 323 ALA SER ALA MET PRO ASP GLN ARG GLY SER ALA ALA LYS SEQRES 22 B 323 ALA GLU PHE ALA ALA ARG ALA ILE ALA SER ALA HIS GLY SEQRES 23 B 323 ILE GLU LEU PRO PRO PHE ARG ASN GLY ASN VAL SER ASP SEQRES 24 B 323 ILE GLU ALA MET LEU SER GLY GLU GLU GLU PHE VAL GLU SEQRES 25 B 323 LYS TYR ARG SER LEU LEU ASP SER ASP CYS PHE SEQRES 1 C 35 PRO GLU LYS VAL THR VAL VAL PRO LYS PHE GLY ASP TRP SEQRES 2 C 35 ASP GLU ASN ASN PRO SER SER ALA ASP GLY TYR THR HIS SEQRES 3 C 35 ILE PHE ASN LYS VAL ARG GLU GLU ARG SEQRES 1 D 35 PRO GLU LYS VAL THR VAL VAL PRO LYS PHE GLY ASP TRP SEQRES 2 D 35 ASP GLU ASN ASN PRO SER SER ALA ASP GLY TYR THR HIS SEQRES 3 D 35 ILE PHE ASN LYS VAL ARG GLU GLU ARG HET TRS A1501 8 HET TRS B1502 8 HET TRS B1503 8 HET TRS A1504 8 HET ETF A2001 6 HET ETF B2002 6 HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETNAM ETF TRIFLUOROETHANOL HETSYN TRS TRIS BUFFER FORMUL 5 TRS 4(C4 H12 N O3 1+) FORMUL 9 ETF 2(C2 H3 F3 O) FORMUL 11 HOH *321(H2 O) HELIX 1 1 GLU A 38 CYS A 43 1 6 HELIX 2 2 THR A 59 ARG A 82 1 24 HELIX 3 3 SER A 87 LYS A 102 1 16 HELIX 4 4 LEU A 103 LEU A 103 5 1 HELIX 5 5 GLU A 107 PRO A 108 5 2 HELIX 6 6 LEU A 109 SER A 115 1 7 HELIX 7 7 TYR A 131 ASP A 140 1 10 HELIX 8 8 ASP A 183 GLY A 199 1 17 HELIX 9 9 GLY A 199 ASN A 211 1 13 HELIX 10 10 ASN A 219 SER A 221 5 3 HELIX 11 11 TYR A 222 ILE A 238 1 17 HELIX 12 12 SER A 243 MET A 262 1 20 HELIX 13 13 GLY A 267 HIS A 283 1 17 HELIX 14 14 VAL A 295 LEU A 302 1 8 HELIX 15 15 GLY A 304 LEU A 316 1 13 HELIX 16 16 GLU B 38 CYS B 43 1 6 HELIX 17 17 THR B 59 ARG B 82 1 24 HELIX 18 18 SER B 87 LYS B 102 1 16 HELIX 19 19 LEU B 109 SER B 115 1 7 HELIX 20 20 TYR B 131 ASP B 140 1 10 HELIX 21 21 ASP B 183 GLY B 199 1 17 HELIX 22 22 GLY B 199 ASN B 211 1 13 HELIX 23 23 ASN B 219 SER B 221 5 3 HELIX 24 24 TYR B 222 ILE B 238 1 17 HELIX 25 25 SER B 243 MET B 262 1 20 HELIX 26 26 GLY B 267 HIS B 283 1 17 HELIX 27 27 VAL B 295 LEU B 302 1 8 HELIX 28 28 GLY B 304 LEU B 316 1 13 HELIX 29 29 GLY C 152 GLU C 156 5 5 HELIX 30 30 GLY D 152 GLU D 156 5 5 SHEET 1 A 6 HIS A 145 ASP A 151 0 SHEET 2 A 6 GLY A 155 LEU A 168 -1 O LEU A 157 N MET A 149 SHEET 3 A 6 ASN A 171 ALA A 181 -1 O LEU A 175 N GLN A 164 SHEET 4 A 6 ARG A 214 ASP A 216 -1 O ASP A 216 N THR A 177 SHEET 5 A 6 THR A 121 PRO A 126 -1 N THR A 125 O ILE A 215 SHEET 6 A 6 HIS C 167 ASN C 170 -1 O HIS C 167 N VAL A 124 SHEET 1 B 6 HIS B 145 ASP B 151 0 SHEET 2 B 6 GLY B 155 LEU B 168 -1 O LEU B 157 N MET B 149 SHEET 3 B 6 ASN B 171 ALA B 181 -1 O VAL B 180 N LYS B 160 SHEET 4 B 6 ARG B 214 ASP B 216 -1 O ASP B 216 N THR B 177 SHEET 5 B 6 THR B 121 PRO B 126 -1 N THR B 125 O ILE B 215 SHEET 6 B 6 HIS D 167 ASN D 170 -1 O HIS D 167 N VAL B 124 CISPEP 1 LYS A 129 PRO A 130 0 0.27 CISPEP 2 LYS B 129 PRO B 130 0 0.34 SITE 1 AC1 7 ASP A 143 TYR A 162 ARG A 163 THR A 165 SITE 2 AC1 7 GLY A 304 HOH A1026 HOH A1268 SITE 1 AC2 6 TYR B 131 ALA B 269 VAL B 295 ASP B 297 SITE 2 AC2 6 HOH B1324 ETF B2002 SITE 1 AC3 3 THR B 118 ASP B 120 HOH B1310 SITE 1 AC4 7 ALA A 48 TRP A 50 TYR A 131 VAL A 295 SITE 2 AC4 7 ASP A 297 HOH A1318 ETF A2001 SITE 1 AC5 6 ARG A 266 GLY A 267 ALA A 269 HOH A1217 SITE 2 AC5 6 TRS A1504 HOH C1118 SITE 1 AC6 6 ARG B 266 GLY B 267 ALA B 269 HOH B1082 SITE 2 AC6 6 TRS B1502 HOH D1035 CRYST1 45.884 58.166 119.767 90.00 89.92 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021794 0.000000 -0.000029 0.00000 SCALE2 0.000000 0.017192 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008350 0.00000